Idioma:

Arterial Hypertension, Aldosterone, and Atrial Fibrillation

Seccia, Teresa M. ; Caroccia, Brasilina ; Maiolino, Giuseppe ; Cesari, Maurizio ; Rossi, Gian Paolo

Current hypertension reports, 2019-12, Vol.21 (12), p.94-5, Article 94 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por

Enviar para

Título:
Arterial Hypertension, Aldosterone, and Atrial Fibrillation
Autor: Seccia, Teresa M. ; Caroccia, Brasilina ; Maiolino, Giuseppe ; Cesari, Maurizio ; Rossi, Gian Paolo
Assuntos: Aging ; Cardiac arrhythmia ; Cardiology ; Cardiomyocytes ; Drug dosages ; Family Medicine ; General Practice ; Heart failure ; Hospitalization ; Hypertension ; Internal Medicine ; Mechanisms of Hypertension and Target-Organ Damage (JE Hall and ME Hall ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Nephrology ; Primary Care Medicine ; Section Editors ; Studies ; Topical Collection on Mechanisms of Hypertension and Target-Organ Damage
É parte de: Current hypertension reports, 2019-12, Vol.21 (12), p.94-5, Article 94
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição: Purpose Atrial fibrillation is the most common sustained arrhythmia, with a prevalence of 1–2% in the general population and over 15% in people older than 80 years. Due to aging of the population it imposes an increasing burden on the healthcare system because of the need for life-long pharmacological treatment and the associated increased risk of heart failure and hospitalization. Hence, identification of the factors that predispose to atrial fibrillation it is of utmost relevance. Recent Findings Several conditions exist that are characterized by inappropriately high levels of aldosterone, mostly primary aldosteronism and the severe or drug-resistant forms of arterial hypertension. In these forms, aldosterone can cause prominent target organ damage, mostly in the heart, vasculature, and kidney. Summary This review examines the experimental data and clinical evidences that support a link between hyperaldosteronism and atrial fibrillation, and how this knowledge should lead to a change in our management of the hypertensive patients presenting with atrial fibrillation.
Editor: New York: Springer US
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Arterial Hypertension, Aldosterone, and Atrial Fibrillation

Seccia, Teresa M. ; Caroccia, Brasilina ; Maiolino, Giuseppe ; Cesari, Maurizio ; Rossi, Gian Paolo

New York: Springer US

Buscando em bases de dados remotas. Favor aguardar.